We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Rapid Test Detects Both HIV and TB in Blood Sample

By LabMedica International staff writers
Posted on 21 Nov 2023
Print article
Image: The new and rapid test detects both HIV and tuberculosis at the same time with a small amount of blood (Photo courtesy of Tulane University)
Image: The new and rapid test detects both HIV and tuberculosis at the same time with a small amount of blood (Photo courtesy of Tulane University)

HIV and tuberculosis (TB) frequently occur together, posing a significant health challenge. HIV weakens the immune system, increasing susceptibility to infections like TB. Indeed, individuals with HIV are at the greatest risk of developing TB. Traditional TB diagnosis involves culturing sputum, saliva, and mucus mix, but this process is time-consuming and often not feasible for urgent treatment needs. Additionally, sputum collection is not viable for HIV patients due to their compromised immune systems. To fill this diagnostic gap, researchers have developed a rapid, dual-detection blood test that can identify both HIV and TB simultaneously using just a small blood sample.

This breakthrough blood test, developed by researchers at Tulane University (New Orleans, LA, USA), not only identifies HIV and TB but also measures their respective viral and bacterial loads. Requiring only about 200 microliters of blood – a mere few drops – the test bypasses the need for sputum samples, making it particularly useful for HIV patients. It operates by targeting specific HIV and TB antigens present in the blood, utilizing mass spectrometry for precise measurement of viral and bacterial quantities.

A key benefit of this novel test is its ability to monitor the levels of both HIV and TB during a patient's treatment. This real-time tracking is crucial in managing immune reconstitution inflammatory syndrome (IRIS), a condition where treating one infection may exacerbate the other. The test's rapid results allow for timely adjustments in treatment strategies, enhancing patient outcomes. Such tests are especially critical in developing countries, where TB is more prevalent and access to diagnostic resources is limited. The researchers are optimistic about progressing from their initial pilot study to clinical trials and are aiming for FDA approval of the test.

“For HIV patients, their immune system is very weak, and once they are infected, they can’t confront the bacteria very well, so that’s why there is this urgent need to bring a blood-based TB tests to them,” said Tony Hu at Tulane University School of Medicine who led the research. “For the TB-infected patients, they worry, ‘Why did I get TB? Is it because I have HIV?’ So, this is a multiplex detection to cover both pathogens.”

Related Links:
Tulane University

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Microbiology

view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more

Pathology

view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.